In general, despite the limitations of insufficient SNP coverage in candidate genes and not generalized to the entire population, further genetic studies are needed to evaluate further or confirm the role of GCKR gene in NAFLD. This evidence concerns the gene GCKR and metabolic dysfunction-associated steatotic liver disease.